Achieve Therapeutic Localization with Selective, Effective & Validated Delivery to Intracellular Targets Optimize Your Pipeline’s Therapeutic Index with Novel Delivery Systems to Overcome Endosomal Barriers in Target Cells Selective cell […]

SAE Media Group is proud to present its 4th Annual AI in Drug Discovery Conference, taking place from 13 – 14 March 2023 in London, UK. With the recent pandemic […]

As the gene therapy field continues to break records, there are still significant challenges to overcome relating to safety, efficacy, and accessibility. The 6th Annual Gene Therapy for Rare Disorders […]

Patient-first. Collaborative. Data and insights driven. Digitally underpinned. These are the qualities of a healthcare system that actively serves its purpose – yet instead, the US is hindered by mounting […]

Dedicated to driving cost-effective, efficacious, safe, durable, scalable, and globally accessible allogeneic, cell-based, and engager therapies, the 8th Innate Killer Summit returns to cement your end-to-end education in innate immune therapeutics. […]

The first TCR-based therapy approval in the US and Europe at the start of last year sparked a rush of excitement, investment and collaborations. As further developers move into the […]

Hijacking E3 Ligases to Mediate Degradation & Modulation of Undrugged Targets As a family of over 600 known proteins, ligases pose immense potential as viable avenues for harnessing previously undrugged […]

Turbocharging Your Next Gen LNP End-To-End Development to Deliver Curative Promises to Patients Following exciting industry updates from Verve Therapeutics’ GalNAc-LNP for PCSK9 for HFpEF treatment, to Recode’s 5th element, […]

The field of FcRn receptor targeting is gaining ground-breaking speed as Argenx, Janssen, UCB and Immunovant compete to tackle myasthenia gravis and biopharma invest in transformative immunological therapy for autoimmune […]

mRNA therapeutics have catapulted into the limelight amidst the COVID-19 pandemic with multiple EMA approvals to help combat the virus. Bringing together KOLs sharing case studies with actionable insights, the […]

10th Annual Pre-Filled Syringes East Coast Conference April 24 – 25, 2023 Boston, USA Driving Innovations in Device Design, Connectivity and Sustainability for Advanced Parenteral Combination Product https://www.pfsamericas.com/PJ-Event-listing The 10th […]

Welcome to the Next Generation Cardiovascular Drug Development Summit Executing Cell & Gene Therapy for Cardiac Regeneration Following technology advancements and the surge of investment in developing the next generation […]

The 5th Annual Cell Engager Summit is back in Boston, MA this year – the only industry-led meeting bringing together 100+ pharma and biotech leaders will assemble for a 3-day agenda including 4 unique pre-conference […]

With increasing prioritization for neuroscience discovery, huge biopharma is investing in expanding its departments, focusing on glial biology, neuroinflammatory biomarkers, and optimizing various approaches to target the likes of LRKK2, […]

Uniting the leading minds in gene therapy at the Gene Therapy Durability Summit, join us to: Leverage knowledge from current clinical trials with relevant durability data across a range of […]

The 2nd ADC Analytical Development Summit (April 25-27, 2023 | Boston, MA) is the only meeting focused on optimizing the application of analytical technologies for ADC, from drug-linker and drug […]

6th Annual Pharmaceutical Microbiology USA Conference April 26 – 27, 2023 Boston, MA, USA http://www.pharma-microbiology-usa.com/PharmaJournalistWL Sponsored by: LONZA Chaired by: Donald Singer, USP General Chapter Committee Microbiology Chair, US Pharmacopeia  Contamination […]

Uniting leading CMC, Regulatory, QC, Analytical and Process Development experts, the 4th Annual Gene Analytical Development Europe Summit is the industry’s definitive and only meeting focused on tackling the greatest […]

Facilitating key conversations needed to drive forward the development of safe and effective innate stimulating immunotherapies, the 4th STING & TLR Targeting Therapies Summit will take place, for the first time […]

The Global High Potency API/HPAPI Market is projected to reach 37 billion USD by 2027, growing at an ever-increasing CAGR of 8.43%. The expanding production of high potency APIs, along […]

Exploring Injectable Drug Formulations and Device Development Sponsors: Victrex Exhibitors: PHC Group  As Part of Europe’s leading Injectable conference series, the 5th annual Injectable Drug Delivery conference will assess innovations […]

It’s a painful moment for healthcare. We face rampant burn out, squeezed operating margins, unhappy patients, massive cost pressures and more competition than ever as disruptors continue to flood the […]

With 3 days of jam-packed content and 35+ world class speakers pioneering the next wave of ALS therapies, the 2nd ALS Drug Development Summit is biopharma’s can’t-miss meeting for the acceleration of ALS […]

With investment into the Treg field at an all time high, excitement is overflowing at the prospect of these remarkable cells being game-changers in the long-term treatment of autoimmunity, inflammation and transplantation. As this […]

The 2nd Cell Therapy Potency Assay will gather 100+ experts working to rationally design better potency assays to smooth the path to regulatory approval and minimize hold times with scientifically rigorous and informative potency measurements. Whether […]

Whether it’s in cardiovascular disease, Alzheimer’s or osteoarthritis, therapeutic innovations to target the mechanisms of aging are making significant headway to clinical trials. With increased investments and recognition, along with […]

With approvals in siRNA technology, more ASOs hurtling towards human trials in neurology, and exciting headlines in Alzheimer’s and ALS, the draw of CNS targets for oligonucleotides has never been […]

Returning as the pinnacle event in the industry, the 4th Annual Gene Therapy for Neurological Disorders Summit Europe (6-8 June 2023, Amsterdam) enables you to bring your gene therapy to […]

Assessing Device Development and Regulation for Advanced Innovation Sponsors: Datwyler, Haselmeier, Mitsubishi Gas Chemical, Nemera, ZEON Exhibitors: Credence MedSystems, Kymanox, Noble, Owen Mumford Pharmaceutical Services, SCHERDEL Medtec SAE Media Group’s […]

As the global healthcare system accelerates its acceptance of gene therapies as one-time, potentially curative, treatment options for rare diseases, the role of patient engagement in informing drug development strategy […]